Literature DB >> 10623669

Detection of Epstein-Barr virus in Hodgkin-Reed-Sternberg cells : no evidence for the persistence of integrated viral fragments inLatent membrane protein-1 (LMP-1)-negative classical Hodgkin's disease.

A Staratschek-Jox1, S Kotkowski, G Belge, T Rüdiger, J Bullerdiek, V Diehl, J Wolf.   

Abstract

Classical Hodgkin's disease (HD) is associated with Epstein-Barr virus (EBV) infection. Although in developing countries EBV can be demonstrated in Hodgkin-Reed-Sternberg (H-RS) cells in up to 95% of HD cases, in industrialized countries only about 50% of HD cases are associated with EBV. An open question remains whether EBV in the EBV-negative cases has escaped detection by standard screening procedures due to deletions in the viral genome associated with integration of viral fragments into the host cell genome. We, among others, recently described this phenomenon in Burkitt's lymphoma cells. To investigate whether H-RS cells in latent membrane protein-1 (LMP-1)-negative HD cases harbor fragments of the EBV genome, we combined fluorescence in situ hybridization (FISH) using a set of six overlapping DNA probes spanning the whole EBV genome with immunophenotyping of fresh frozen lymphoma sections. Results in the eight cases analyzed were as follows: in three LMP-1-positive cases, FISH analysis yielded specific signals for each EBV DNA probe in H-RS cells, which had been identified by morphology and CD30 staining. In contrast, none of the EBV DNA probes hybridized to the H-RS cells in the five LMP-1-negative cases. Thus, there is no evidence for the presence of fragments of the viral genome integrated into the host cell genome in the LMP-1-negative cases. Furthermore, in the LMP-1-positive cases analyzed, no large deletions in the viral genome were detected. These results show that, in classical HD, LMP-1-negative cases do not harbor EBV DNA within the H-RS cells. Whether, in these cases, a still unknown virus contributes to the transformation and maintenance of the malignant phenotype remains to be established.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10623669      PMCID: PMC1868626          DOI: 10.1016/S0002-9440(10)64721-9

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  25 in total

1.  Distribution and phenotype of Epstein-Barr virus-harboring cells in Hodgkin's disease.

Authors:  H Herbst; E Steinbrecher; G Niedobitek; L S Young; L Brooks; N Müller-Lantzsch; H Stein
Journal:  Blood       Date:  1992-07-15       Impact factor: 22.113

2.  The Epstein-Barr virus LMP1 gene product induces A20 zinc finger protein expression by activating nuclear factor kappa B.

Authors:  C D Laherty; H M Hu; A W Opipari; F Wang; V M Dixit
Journal:  J Biol Chem       Date:  1992-12-05       Impact factor: 5.157

3.  Epstein-Barr virus and Hodgkin's disease. A correlative in situ hybridization and polymerase chain reaction study.

Authors:  L M Weiss; Y Y Chen; X F Liu; D Shibata
Journal:  Am J Pathol       Date:  1991-12       Impact factor: 4.307

4.  Rapid subchromosomal localization of cosmids by nonradioactive in situ hybridization.

Authors:  T Kievits; J G Dauwerse; J Wiegant; P Devilee; M H Breuning; C J Cornelisse; G J van Ommen; P L Pearson
Journal:  Cytogenet Cell Genet       Date:  1990

5.  Evidence for integrated EBV genomes in Raji cellular DNA.

Authors:  M Anvret; A Karlsson; G Bjursell
Journal:  Nucleic Acids Res       Date:  1984-01-25       Impact factor: 16.971

6.  Detection of EBV gene expression in Reed-Sternberg cells of Hodgkin's disease.

Authors:  T C Wu; R B Mann; P Charache; S D Hayward; S Staal; B C Lambe; R F Ambinder
Journal:  Int J Cancer       Date:  1990-11-15       Impact factor: 7.396

7.  Suppression of the malignant phenotype in somatic cell hybrids between Burkitt's lymphoma cells and Epstein-Barr virus-immortalized lymphoblastoid cells despite deregulated c-myc expression.

Authors:  J Wolf; M Pawlita; J Bullerdiek; H zur Hausen
Journal:  Cancer Res       Date:  1990-05-15       Impact factor: 12.701

8.  Demonstration of monoclonal EBV genomes in Hodgkin's disease and Ki-1-positive anaplastic large cell lymphoma by combined Southern blot and in situ hybridization.

Authors:  I Anagnostopoulos; H Herbst; G Niedobitek; H Stein
Journal:  Blood       Date:  1989-08-01       Impact factor: 22.113

9.  Down-regulation of integrated Epstein-Barr virus nuclear antigen 1 and 2 genes in a Burkitt lymphoma cell line after somatic cell fusion with autologous EBV-immortalized lymphoblastoid cells.

Authors:  J Wolf; M Pawlita; B Klevenz; B Frech; U K Freese; N Müller-Lantzsch; V Diehl; H zur Hausen
Journal:  Int J Cancer       Date:  1993-02-20       Impact factor: 7.396

10.  Epstein-Barr virus and Hodgkin's disease: a comparative immunological, in situ hybridization, and polymerase chain reaction study.

Authors:  A F Lauritzen; U Hørding; H W Nielsen
Journal:  APMIS       Date:  1994-07       Impact factor: 3.205

View more
  9 in total

Review 1.  Gammaherpesviruses and "Hit-and-Run" oncogenesis.

Authors:  R F Ambinder
Journal:  Am J Pathol       Date:  2000-01       Impact factor: 4.307

Review 2.  Hodgkin's disease and the Epstein-Barr virus.

Authors:  K J Flavell; P G Murray
Journal:  Mol Pathol       Date:  2000-10

3.  Epstein-Barr virus in human malignancy: a special reference to Epstein-Barr virus associated gastric carcinoma.

Authors:  Mee Soo Chang; Woo Ho Kim
Journal:  Cancer Res Treat       Date:  2005-10-31       Impact factor: 4.679

4.  A collaborative nationwide lymphoma study in Lebanon: incidence of various subtypes and analysis of associations with viruses.

Authors:  Zaher K Otrock; Jad Saab; Georges Aftimos; Fady Nasr; Fadi S Farhat; Saad Khairallah; Gérard Abadjian; Marwan Ghosn; Hassan Sidani; Ahmad Ibrahim; Ayman Tawil; Claude Ghorra; Zarouhie Meguerian; Walid Mokaddem; Walid Dayeh; Ziad Salem; Georges Chahine; Nizar Bitar; Anas Mugharbel; Joseph Makdessi; Christina Khater; Mirna El Hajj; Dany Abi Gerges; Charles Sfeir; Joseph Kattan; Khaled Ibrahim; Michel Saade; Hussein Sadek; Rami A Mahfouz; Mohamed A Kharfan-Dabaja; Ghazi Zaatari; Ali Bazarbachi
Journal:  Pathol Oncol Res       Date:  2013-05-08       Impact factor: 3.201

5.  A defective, rearranged Epstein-Barr virus genome in EBER-negative and EBER-positive Hodgkin's disease.

Authors:  Yan-Jun Gan; Bassem I Razzouk; Tao Su; John W Sixbey
Journal:  Am J Pathol       Date:  2002-03       Impact factor: 4.307

Review 6.  Hodgkin's lymphoma and CD30 signal transduction.

Authors:  Ryouichi Horie; Masaaki Higashihara; Toshiki Watanabe
Journal:  Int J Hematol       Date:  2003-01       Impact factor: 2.490

7.  [Extranodal manifestation of classical Hodgkin lymphoma in the head and neck region].

Authors:  H-U Völker; E Becker; H-K Müller-Hermelink; M Scheich
Journal:  HNO       Date:  2020-01       Impact factor: 1.284

Review 8.  Contribution of the Epstein Barr virus to the molecular pathogenesis of Hodgkin lymphoma.

Authors:  G Kapatai; P Murray
Journal:  J Clin Pathol       Date:  2007-12       Impact factor: 3.411

Review 9.  Molecular Pathogenesis of Hodgkin Lymphoma: Past, Present, Future.

Authors:  Marc Bienz; Salima Ramdani; Hans Knecht
Journal:  Int J Mol Sci       Date:  2020-09-10       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.